Bio-Rad Laboratories
BIO
$358.45
Share price
0.65%
Change (1 day)
-34.65%
Change (1 year)
Categories
Bio-Rad Laboratories, Inc. is an American manufacturer of products for the life science research and clinical diagnostics markets.
Bio-Rad Laboratories (BIO) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $3.53 B
According to Bio-Rad Laboratories's latest financial reports the company's total liabilities are $3.53 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Bio-Rad Laboratories - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $3.88 B | -5.41% |
| 2021-12-31 | $4.10 B | 32.85% |
| 2020-12-31 | $3.09 B | 37.22% |
| 2019-12-31 | $2.25 B | 41.94% |
| 2018-12-31 | $1.58 B | 18.35% |
| 2017-12-31 | $1.34 B | 6.17% |
| 2016-12-31 | $1.26 B | 3.5% |
| 2015-12-31 | $1.22 B | 5.61% |
| 2014-12-31 | $1.15 B | -3.82% |
| 2013-12-31 | $1.20 B | -15.04% |
| 2012-12-31 | $1.41 B | 4.62% |
| 2011-12-31 | $1.35 B | -11.16% |
| 2010-12-31 | $1.52 B | 21.14% |
| 2009-12-31 | $1.25 B | 30% |
| 2008-12-31 | $0.96 B | 0.12% |
| 2007-12-31 | $0.96 B | 24.32% |
| 2006-12-31 | $0.77 B | 1.04% |
| 2005-12-31 | $0.76 B | -3.33% |
| 2004-12-31 | $0.79 B | 61.92% |
| 2003-12-31 | $0.49 B | 45.45% |
| 2002-12-31 | $0.33 B | -15.63% |
| 2001-12-31 | $0.40 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $125.10 B | 3,442.56% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | $50.19 B | 1,321.27% | 🇺🇸 USA |
 Agilent Technologies A | $5.11 B | 44.90% | 🇺🇸 USA |
 Becton Dickinson BDX | $27.08 B | 666.85% | 🇺🇸 USA |
 General Electric GE | $130.63 B | 3,599.39% | 🇺🇸 USA |
 Danaher DHR | $33.17 B | 839.53% | 🇺🇸 USA |
 PerkinElmer
PKI | $6.60 B | 87.02% | 🇺🇸 USA |